EVIO Announces New Cannabis Testing Lab in California
The Palm Desert facility will offer comprehensive compliance testing services in addition to research and development into new cannabis products.
CBD Market Set to Grow as Regulatory Change Looms in U.S.
The market for cannabis and hemp products has seen a low-key but potentially huge step forward in recent weeks.
Content of Cannabis Used to Treat Kids with Epilepsy Revealed
An Australian study of medicinal cannabis used to treat childhood epilepsy has found most samples contained some THC and little CBD, contrary to parents' expectations.
Study Finds no Strong Evidence That Cannabis Reduces Chronic Pain
A four-year study suggests medicinal cannabis is not as effective at relieving chronic non-cancer pain as commonly assumed.
Australian GPs Cautiously Supportive of Medicinal Cannabis Access
A majority of Australian GPs support medicinal cannabis being available on prescription, with their preferred "access model" involving trained GPs prescribing independently of specialists.
Cannabinoids Could Play a Role in Destroying Cancer Cells
While cannabis hasn’t been shown to cure cancer on its own, despite the pervasiveness of anecdotal stories, scientists have found that cannabinoids have anti-cancer properties that could be helpful in drug development.
UCSF Researchers Excited About FDA Approval of Epidiolex
In 2013, UCSF Benioff Children’s Hospital San Francisco became the first site to administer the drug in a child, and as of this week, the FDA has approved its use in two rare and devastating forms of epilepsy.
Steep Hill Pennsylvania Achieves ISO 17025 Accreditation for Cannabis Testing
The lab will run full-service testing for cannabinoid profiles, terpenes, pesticides, heavy metals, biological screening, and residual solvents, testing for 10+ cannabinoids and 40+ terpenes.
FDA Grants Orphan Drug Designation for Another Cannabis-derived Drug
The designation has been given to Revive Therapeutics for the use of CBD in treating autoimmune hepatitis.
